FDCP
TMO icon

Foster Dykema Cabot & Partners’s Thermo Fisher Scientific TMO Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9M Sell
41,685
-3,418
-8% -$1.64M 1.22% 24
2026
Q1 		$22.2M Sell
45,103
-137
-0.3% -$74.3K 1.41% 24
2025
Q4 		$26.2M Buy
45,240
+514
+1% +$291K 1.61% 20
2025
Q3 		$21.7M Sell
44,726
-223
-0.5% -$104K 1.42% 26
2025
Q2 		$18.2M Buy
44,949
+62
+0.1% +$25.9K 1.28% 25
2025
Q1 		$22.4M Sell
44,887
-425
-0.9% -$230K 1.79% 20
2024
Q4 		$23.6M Buy
45,312
+2,173
+5% +$1.19M 1.84% 20
2024
Q3 		$26.7M Sell
43,139
-2
-0% -$1.18K 2.24% 16
2024
Q2 		$23.9M Buy
43,141
+424
+1% +$243K 2.14% 20
2024
Q1 		$24.8M Buy
42,717
+695
+2% +$390K 2.31% 17
2023
Q4 		$22.3M Buy
+42,022
New +$20.3M 2.36% 15

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Foster Dykema Cabot & Partners's TMO Position: Q2 2026 in Review

Foster Dykema Cabot & Partners reduced its Thermo Fisher Scientific (TMO) stake by 7.6% in Q2 2026, selling an estimated $1.64M and leaving 41,685 shares worth $20.9M. The position accounts for 1.22% of the portfolio, ranked #24.

Foster Dykema Cabot & Partners first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $26.7M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Foster Dykema Cabot & Partners held 41,685 shares of Thermo Fisher Scientific worth $20.9M as of Q2 2026.
  • Foster Dykema Cabot & Partners sold 3,418 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.64M.
  • Thermo Fisher Scientific made up 1.22% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #24 holding.
  • Foster Dykema Cabot & Partners first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Foster Dykema Cabot & Partners's Thermo Fisher Scientific position peaked at $26.7M in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.